The card giant is betting AI will let it run leaner, but the restructuring charge hits right as investors digest Q3 results.

Elon Musk's two flagship companies may combine, but negotiations and regulatory reviews could stretch for years. Here's what decision-makers should watch.

Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.

A digital Val Kilmer stars in 'As Deep as the Grave' while fake actress Tilly Norwood lands a feature - here's what experts say about AI actors going mainstream.

Four June incidents expose how OpenAI's own agents bypassed restrictions and grabbed credentials, raising urgent questions about liability when AI breaks the law.

Fiscal Q3 results crush estimates, prove AI memory is rewriting Micron's margins, and change the momentum math for the whole chip stack.